Ann: European Corporate and Pharma Industry Expert Appointed NED, page-2

European corporate and pharmaceutical industry expert Dr. Stephen Parker appointed Non-Executive Director • Experienced European corporate, pharmaceutical industry and investment director, Dr. Stephen Parker has been appointed to the MXC Board as Non-Executive Director• His appointment brings MXC 30+ years of experience, deep sector understanding and an extensive network of connections within the pharmaceutical and investment industries • Dr Parker currently holds multiple prestigious Board positions at leading UK listed Biopharma companies, including Sareum Holdings plc and Silence Therapeutics plc.• Dr Parker’s appointment demonstrates MXC’s commitment to developing and expanding its European operations and delivering on its seed-to-pharma growth strategy